Internet Based Emotional Awareness and Expression Therapy for Functional Somatic Disorder With and Without Therapist Support
How Much Does the Therapist Matter in Internet Based Emotional Awareness and Expression Therapy (I-EAET) for Functional Somatic Disorder? A Randomised Controlled Trial of I-EAET With and Without Therapist Support
1 other identifier
interventional
150
1 country
2
Brief Summary
Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chronic primary pain) are very common in primary care. These patients make 14 times more doctor visits than the general population, but describe themselves as less satisfied with the care they receive. Although Region Stockholm in Sweden recently developed care flows based on 'step up' care for the most common patient groups in primary care, patients with functional or medically unexplained symptoms are not mentioned. Short-term psychodynamic therapies such as Emotional Awareness and Expression Therapy (EAET) and Intensive Short Term Psychodynamic Therapy (ISTDP) have recently been evaluated in three systematic reviews and show good results for patients with medically unexplained symptoms. Short-term psychodynamic therapy considers that good treatment outcomes for patients with functional somatic syndromes can be achieved by increasing awareness of emotions and teaching patients to better experience, express and regulate emotions. In several randomized studies, short-term psychodynamic therapy has shown good effects even compared to other treatments, including cognitive behavioral therapy (CBT). The overall purpose of this research project is to to evaluate psychodynamic emotion-focused interventions (EAET and ISTDP) for patients with medically unexplained symptoms/functional somatic symptoms (MUS/FSD). The project includes several studies that will clarify effects and contribute to information on how care flows in primary care for the patient group can be created. The research question for this specific study is: Is internet-based Emotional Awareness and Expression Therapy (I-EAET) with therapist more effective than without therapist support for patients with FSD?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2023
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
February 27, 2024
CompletedFirst Posted
Study publicly available on registry
March 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 12, 2024
March 1, 2024
1.5 years
February 27, 2024
March 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Health Questionnaire -15 (PHQ-15)
Ratings 0-2 on how troublesome somatic symptoms are experienced. Higher scores indicates worse symptom/functioning.
Change from pre to post treatment (after 10 weeks of treatment)
Numeric Rating Scales according to EURONET-SOMA
Visual analogue scale 0-10 for symptom intensity and symptom interference. Higher scores indicates worse symptom/functioning.
Change from pre to post treatment (after 10 weeks of treatment)
Secondary Outcomes (6)
Generalized Anxiety Disorder-7 (GAD-7)
Change from pre to post treatment (after 10 weeks of treatment)
Patient Health Questionnaire-9 (PHQ-9)
Change from pre to post treatment (after 10 weeks of treatment)
Post traumatic stress disorder checklist-5 (PCL-5)
Change from pre to post treatment (after 10 weeks of treatment)
Difficulties in Emotion Regulation Scale-16 (DERS-16)
Change from pre to post treatment (after 10 weeks of treatment)
Sheehan Disability Scale (SDS)
Change from pre to post treatment (after 10 weeks of treatment)
- +1 more secondary outcomes
Other Outcomes (3)
Mediational measure: DERS-16
Each week once a week throughout 10 weeks of treatment
Mediational measure: PHQ-15
Each week once a week throughout 10 weeks of treatment
Mediational measure: PHQ-4
Each week once a week throughout 10 weeks of treatment
Study Arms (2)
I-EAET with therapist support
EXPERIMENTALI-EAET is a 10 week treatment intervention combining principles from emotion focused therapies and neuroscience. Main components include psychoeducation on the body-mind connection, anxiety regulation with self-compassion exercises and different techniques for emotional exposure and processing. Participants have help from a therapist giving feedback.
I-EAET without therapist support
ACTIVE COMPARATORI-EAET is a 10 week treatment intervention combining principles from emotion focused therapies and neuroscience. Main components include psychoeducation on the body-mind connection, anxiety regulation with self-compassion exercises and different techniques for emotional exposure and processing. Participants works on their own and have only technical support.
Interventions
In I-EAET with therapist support, the therapist and participants communicate asynchronous using written messages. The therapist gives feedback each week on home-work assignments and is available on demand for support. In I-EAET without therapist support, the participants works with home-work assignments on their own and only have technical support.
Eligibility Criteria
You may qualify if:
- The research subject certifies that he/she has undergone medical assessment for his/her physical symptoms.
- The subject rates either moderate distress from bodily symptoms in the PHQ-15 (over 10 points) or severe distress from a single bodily symptom (at least 2 points for this symptom).
- The research participants expresses interest in investigating whether emotional factors such as stress may contribute to symptoms.
- Research subjects either affirm the presence of emotionally difficult life events (affirm at least 1 such event in the Adverse Childhood Experience (ACE-10) or reach the proposed cut-off point of 23p in the PCL-5).
- Drugs used should have been stable for at least 1 month.
You may not qualify if:
- Research subjects suffer from ongoing substance abuse (alcohol or drugs) or are deemed to have serious mental illness (psychotic illness, suicidal ideation, antisocial personality disorder etc).
- The research subjects have ongoing medication of a clearly addictive and sedative nature (e.g. benzodiazepines).
- The research subject participates in other psychological treatment focusing on physical symptoms. However, other psychological treatment is allowed where the support therapy does not take place more often than once a month.
- The research subject does not master the Swedish language sufficiently to be able to assimilate written material in Swedish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Daniel Marotilead
- Wayne State Universitycollaborator
Study Sites (2)
Stockholm University
Stockholm, 10691, Sweden
Stockholm University
Stockholm, 11419, Sweden
Related Links
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD, principal investigator
Study Record Dates
First Submitted
February 27, 2024
First Posted
March 8, 2024
Study Start
December 1, 2023
Primary Completion
June 1, 2025
Study Completion
December 31, 2025
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
Original data shared on demand from other researchers and after approval from Swedish Ethical Review Authority.